News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Lawrence Boise: Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma
Photo from Lawrence Boise/LinkedIn
Jan 8, 2024, 15:21

Lawrence Boise: Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma

Quoting Lawrence Boise, R. Randall Rollins Chair in Oncology at Emory University School of Medicine, on LinkedIn:

”I’m hiring! Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma. Come join the highly collaborative Winship Multiple Myeloma Team. Apply here.”

Source: Lawrence Boise/LinkedIn

cancer career opportunity cell survival Lawrence Boise mitochondrial priming multiple myeloma OncoDaily Oncology postdocs Winship Multiple Myeloma Team
Special Coverage
Blog
Sep 2, 2024, 11:10
Mark James C.: Part 2 of my Cancer Research UK challenge at 15000ft in memory of mum and all those who've lost loved ones to cancer
Blog
Sep 2, 2024, 11:00
Our board members are ready to commemorate Gold September - Childhood Cancer International
Opinion
Sep 2, 2024, 10:54
David Fajgenbaum: It's a common misconception that approval marks the peak of a drug's journey
Blog
Sep 2, 2024, 10:42
Denise De la Cruz: Congrats to our Mary Fletcher Memorial Heart of Caring Award recipients
Blog
Sep 2, 2024, 10:12
Kelly Anderson: Gut microbiome and cancer outcomes holds great potential for future research and treatments
Blog
Sep 2, 2024, 10:00
The MDS Foundation has transformed the narrative surrounding Myelodysplastic Syndromes
Blog
Sep 2, 2024, 09:49
Bayo Curry-Winchell is a mission to make health info accessible and engaging through social media and podcasts - Women In Medicine
Insight
Sep 2, 2024, 09:38
Antonio Passaro: EMA approves amivantamab in combination with chemo for treatment of dvanced EGFR-mutated NSCLC after Osimertinib
Insight
Sep 2, 2024, 09:24
Patrick R. Benusiglio: Pathogenic germline variants were identified in patients with lung cancer
Insight
Sep 2, 2024, 09:12
George Pentheroudakis: We propose a research and regulatory framework for validation/graduation of tumour-agnostic therapies and biomarkers
Blog
Sep 2, 2024, 09:08
Sebastian Szmit: Honored to speak during Congress of the ECO
Blog
Sep 2, 2024, 09:04
Wafik El-Deiry: Some good reads in the August 23, 2024 issue of Science Magazine